NCT06039085 Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
| NCT ID | NCT06039085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ryan J. Halter |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-11-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-11-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
Eligibility Criteria
Inclusion Criteria: 1. Clinical diagnosis of prostate cancer requiring RARP. 2. Ability to understand and the willingness to sign a written informed consent document. 3. Age ≥ 18 years old Exclusion Criteria: 1. Adults with implanted electrical devices such as pacemakers 2. Prisoners 3. Adults with impaired decision-making capacity 4. Any condition for which, in the opinion of the investigator, contraindicates study participation.
Contact & Investigator
Ryan J Halter, PhD
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock, Manchester
Frequently Asked Questions
Who can join the NCT06039085 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06039085 currently recruiting?
Yes, NCT06039085 is actively recruiting participants. Contact the research team at Ryan.J.Halter@dartmouth.edu for enrollment information.
Where is the NCT06039085 trial being conducted?
This trial is being conducted at Lebanon, United States.
Who is sponsoring the NCT06039085 clinical trial?
NCT06039085 is sponsored by Ryan J. Halter. The principal investigator is Ryan J Halter, PhD at Dartmouth-Hitchcock, Manchester. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.